Shares of Cara Therapeutics Inc., a clinical-stage biotech company with a focus on treating pain and pruritus, rocketed higher by as much as 11% during Wednesday’s trading session after providing an update to its phase 3 trial involving kappa opioid receptor agonist CR845.
Tag Archives: Trial
A new cannabis study published in the New England Journal of Medicine saw a nearly 40 percent drop in seizures for participants who were using the marijuana derivative called cannabidiol.
NEW YORK, May 24, 2017 /Weed Wire/ – After years of anecdotal claims about its benefits, the cannabis derivative cannabidiol reduced seizure frequency 39 percent for patients with Dravet syndrome—a rare, severe form of epilepsy—in the first large-scale, randomized clinical trial for the compound.
DEVON, Penn., March 13, 2017 /Weed Wire/ — Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), a clinical-stage specialty pharmaceutical company dedicated to the development of innovative transdermal synthetic cannabinoid treatments, today announced that it has completed enrollment in the Phase 2 STAR 1 (Synthetic Transdermal Cannabidiol for the Treatment of Epilepsy) clinical trial evaluating ZYN002 cannabidiol (CBD) gel in adult epilepsy patients with refractory focal seizures.
Sue Sisley, M.D., is leading the way in studying medical marijuana and post-traumatic stress disorder. In her talk, “Coping With PTSD,” hear Sisley discuss the first clinical trial to study the effects of medical marijuana in the treatment of post-traumatic stress disorder in military veterans.
Could cannabis-infused chewing gum be a potential solution for IBS sufferers? The Doctors discuss a new medical trial in the Netherlands with promising results.
Mara Gordon is a world-renowned expert on cannabis and cancer. Through her nonprofit Aunt Zelda’s, she has worked with more than 600+ patients (mostly cancer cases), using cannabis medicine as well as several other supplements.
While many investors were drawn in by the myth that millions would be made by investing in the companies that purportedly planned to cultivate and sell medical and leisure based marijuana, they should have been focused on investing in companies that are intent on utilizing the plant’s cannabinoid properties, which are consistently demonstrating extraordinary benefit in treating a host of medical conditions.
The combat between sovereign authorities on the one hand and the people who pursue the drug trade on the other—inclusive of the marijuana trade—where it remains criminal, has become frighteningly militarized in recent decades.
On Tuesday, March 3, 2015, a federal jury acquitted a family of medical marijuana patients on four out five federal charges pressed against them.
According to Americans for Safe Access, a new judge has been assigned to the high profile medical marijuana case of the Kettle Falls Five.
America is two nations when it comes to marijuana: in one it’s legal, in the other it’s not. The result is that people like B.J. Patel are going to jail.